Ticlopidine-carbamazepine interaction in a coronary stent patient

Canadian Journal of Cardiology

Volumn 13, Issue 9, 1997, Pages 853-854

  Brown, Robert I G ^a,b   Cooper, Todd G ^a  

^a ROYAL COLUMBIAN HOSPITAL   (Canada)

^b NONE   (Canada)

Author keywords

Carbamazepine; Coronary stenting; Drug interactions; Ticlopidine

Indexed keywords

CARBAMAZEPINE; TICLOPIDINE;

AGED; ARTICLE; ATAXIA; CASE REPORT; CLINICAL FEATURE; DROWSINESS; DRUG BLOOD LEVEL; EPILEPSY; HUMAN; MALE; NEUROLOGIC DISEASE; TRANSLUMINAL CORONARY ANGIOPLASTY; VERTIGO;

AGED; ANTICONVULSANTS; CARBAMAZEPINE; CORONARY DISEASE; DRUG INTERACTIONS; EPILEPSY; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; STENTS; TICLOPIDINE;

EID: 0030813711     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Lablanche J-M, McFadden EP, Bonnet J-L, et al. Combined antiplatelet therapy with ticlopidine and aspirin: a simplified approach to intracoronary stent management. Eur Heart J 1996;17:1373-80.
2. Title LM, Sreenivasan B, Fitzgerald N, et al. Is coronary stenting with ticlopidine more cost effective than coumadin in preventing repeat revascularization? Can J Cardiol 1996;12(Suppl E):158E. (Abst 317)
3. Pan M, Suarez De LezoJ, Velasco F, et al. Reduction of thrombotic and hemorrhagic complications after stent implantation. Am Heart J 1996;132:1119-26.
4. Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 1997;29:6-12.
5. Levy RH. Cytochrome P-450 isoenzymes and antiepileptic drug interactions. Epilepsia 1995;36(Suppl 5):S8-13.
6. Knudsen JB, Bastain W, Sefton CM, et al. Pharmacokinetics of ticlopidine during chronic oral administration to healthy volunteers and its effects on antipyrine pharmacokinetics. Xenobiotica 1992;22:579-89.
7. Colli A, Buccino G, Cocciolo MS, et al. Ticlopidine-theophylline interaction. Clin Pharmacol Ther 1987;41:358-62.
8. Gidal BE, Sorkness CA, McGill KA, et al. Evaluation of a potential enantioselective interaction between ticlopidine and warfarin in chronically anticoagulated patients. Ther Drug Monit 1995;17:33-8.
9. Riva R, Cerullo A, Albania F, et al. Ticlopidine impairs phenytoin clearance: a case report. Neurology 1996;46:1172-3.
10. Rindone JP, Brvan G. Phenytoin toxicity associated with ticlopidine administration. Arch Intern Med 1996;56:1113.
11. Privitera M, Welty TE. Acute phenvtoin toxicity followed by seizure breakthrough from a ticlopidine-phenytoin interaction. Arch Neurol 1996;53.1191-2.
12. Birmelé B, Lebranchu Y, Bagros P, Nivet H, Furet Y, Pengloan J. Interaction of cyclosporin and ticlopidme. Nephrol Dial Transplant 1991;6:150-1. (Lett)